Catalent, Novo Holdings

Novo Holdings is on track to acquire Catalent, a global contract development and manufacturing organization, in a $16.5 ...
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest approximately $1.20 billion (8.5 billion ...
Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to ...
Novo Holdings, parent company of the pharmaceutical giant Novo Nordisk, is spending $16.5 billion on the acquisition. The ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Find insight on Novo Holdings, Malaysian glove sector and more in the latest Market Talks covering health care.
Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...
Novo Holdings has received the green light for its giant acquisition of the American pharmaceutical manufacturer Catalent, Ritzau reports.According to a stock exchange announcement, all regulatory ...